+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Retinal Detachment Market Size was valued at USD 2.6 Billion in 2022. The Retinal Detachment market Condition Type is projected to grow from USD 2.6 Billion in 2023 to USD 4.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.90% during the forecast period (2023 - 2032). Geriatrics, diabetic retinopathy, and other eye problems are becoming more common, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report.
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
The population is aging, eye diseases like diabetic retinopathy are becoming more common, and other reasons are all contributing to the market's growth. For instance, the CDC predicts that by 2028, 30 million Americans aged 40 and older would have a cataract in at least one eye, up from the current estimate of 20.5 million. The demand for effective surgical methods and treatment options rises as a result of the predicted increase in cataract patients, which is anticipated to fuel market growth over the course of the forecast period.
Additionally, as the incidence of diabetes rises, so does the risk of developing diabetic retinopathy, increasing the need for effective treatments and advancing the market. For example, according to the IDF's 2022 projections, there were around 537 million diabetics in the globe in 2021; this figure is expected to rise to 643 million in 2030 and 784 million in 2045.Therefore, during the next years, the predicted rise in the number of persons with diabetes will be the main factor driving market expansion.
Additionally, glaucoma, dry eye disease, and cataracts are among the eye disorders that more people are learning about. As a result of the rising demand for eye therapies, the market is expected to grow over the next years. For instance, between November 15, 2020, and January 15, 2021, a survey was carried out to ascertain how much the general people in the Hail Region of Saudi Arabia knew about common eye diseases and what can cause them, according to a June 2021 article in Healthcare.31% of survey participants knew about cataracts, 43% knew about glaucoma, 66% knew about dry eyes, and 44% knew about diabetic retinopathy. The same source also stated that men were more knowledgeable than women about eye problems, with 46% of participants being aware of them.
The two key factors anticipated to drive market expansion for the global retinal detachment illness market are advancing technology and an increase in incidences of retinal detachment. It is also projected that a surge in eye operations will fuel market growth. The market is also growing as a result of factors like the aging population, an increase in the prevalence of diabetic retinopathy, and other eye conditions. The need for eye therapies is also growing as more individuals become aware of eye conditions such cataracts, glaucoma, dry eye syndrome, and others. This is anticipated to speed up market expansion over the course of the anticipated year. Thus, driving the Retinal Detachment market revenue.
The global Retinal Detachment market segmentation, based on Condition Type, includes rhegmatogenous retinal detachment, tractional retinal detachment, and exudative retinal detachment. Rhegmatogenous retinal detachment segment dominated the global market in 2022. Rhegmatogenous retinal detachment is growing more prevalent in the elderly population, which is why. According to the United Nations' 2017 "World Ageing Population" report, the number of RRD patients is anticipated to increase along with the world aging population, and early disease discovery aids patients in avoiding financial hardship as a result. According to estimates, rhegmatogenous retinal detachment (RRD), a disorder that could harm eyesight, affects 10 to 18 out of every 100,000 people in the United States.
The global Retinal Detachment market segmentation, based on Treatment, includes photocoagulation (laser surgery), cryopexy (freezing), pneumatic retinopexy, scleral buckling, and vitrectomy. Vitrectomy segment dominated the global market in 2022. This is a result of factors like the rising incidence of retinal disease and the growing burden of diabetic retinopathy.
The global Retinal Detachment market segmentation, based on End User, includes hospitals and clinics, specialty centers, and others. Hospitals and Clinics segment dominated the global Retinal Detachment market in 2022. This is due to the wide range of retinal detachment therapies available, including surgery, laser therapy, and cryotherapy (freezing) in the hospital sector, which may boost the market share over the course of the anticipated time. In addition, hospitals with modern facilities and sufficient funding are equipped to handle the increasing number of patients with this condition.
Download Free Sample to learn more about this report.
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. The North America Retinal Detachment Market dominated this market in 2022 (45.80%). The high prevalence of diabetes-related comorbidities in the area, the aging of the population, effective government initiatives, an increase in research collaborations, the presence of significant players, and the region's strong healthcare system are just a few of the causes. According to data from the CDC, diabetic retinopathy, for example, will be the leading cause of vision loss and blindness among adults in the working age group in the United States by May 2021. By 2050, it is expected that 14.6 million Americans will have diabetic retinopathy. Further, In the North American area, the U.S. Retinal Detachment market had the biggest market share, while the Canada Retinal Detachment market had the quickest rate of expansion.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report.
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Europe Retinal Detachment market accounted for the healthy market share in 2022. The increased prevalence of diabetes in the area is expected to increase demand for retinal eye care, which will benefit the local economy. Further, In the European region, the German Retinal Detachment market had the biggest market share, and the U.K. Retinal Detachment market had the quickest rate of growth.
The Asia Pacific Retinal Detachment market is expected to register significant growth from 2023 to 2032. This is because there are more patients with retinal detachments than ever before, and because people are becoming more aware of the issue. Moreover, In the Asia-Pacific region, the Indian Retinal Detachment market had the quickest rate of growth while China's Retinal Detachment market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Retinal Detachment market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Retinal Detachment sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Retinal Detachment industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Retinal Detachment sector. Major players in the Retinal Detachment market, including Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., and Welch Allyn, are attempting to increase market demand by investing in research and development operations.
The medical technology company Carl Zeiss AG (Carl Zeiss), a division of Carl Zeiss Stiftung AG, manufactures and markets optical and optoelectronic devices. Binoculars, camera and cine lenses, eyeglass lenses, measuring technologies, photomask systems, microscopes, and medical technology products, such as ophthalmic diagnostic and therapeutic devices, are all part of the company's product portfolio. Additionally, it offers planetarium software for use with small, medium, and large projection equipment in sky theatres, star theatres, and universe theatres. Numerous sectors, including those in semiconductor, automotive, mechanical, biomedical, and medical technology, are served by it. The corporation has operations in EMEA, the Americas, and APAC. Oberkochen, Germany is home to Carl Zeiss's corporate headquarters. Carl Zeiss Meditec acquired Kogent Surgical, LLC and Katalyst Surgical, LLC in April 2022 to further strengthen its position in the market.
Owner of a network of specialized eye clinics serving patients from all over India is ASG Eye Hospitals. The organization provides a wide range of eye care treatments for cataracts, diabetic retinopathy, glaucoma, macular degeneration, and eye tumors to aid patients in regaining their vision. In order to address even the most severe eye problems, ASG Eye Hospitals launched a new specialized eye center in Vashi, Navi Mumbai, in December 2022. The facility offers pneumatic retinopexy, vitrectomy, and scleral buckling surgeries for retinal detachment.
· Carl Zeiss Meditec AG
· Meridian AG
· IRIDEX Corporation
· Ellex Medical Lasers Ltd
· FCI
· Millennium Surgical Corp.
· BVM Medical Limited
· Lombart Instrument, Inc.
· Welch Allyn
October 2021: Retina Consultants of America (RCA), a company that helps doctors manage their practices, has added Tennessee Retina, which has nine sites and includes Nashville, Bowling Green, and Crossville.
· Rhegmatogenous Retinal Detachment
· Tractional Retinal Detachment
· Exudative Retinal Detachment
· Photocoagulation (Laser Surgery)
· Cryopexy (Freezing)
· Pneumatic Retinopexy
· Scleral Buckling
· Vitrectomy
· Hospitals and Clinics
· Specialty Centers
· Others
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
Report Scope
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 2.6 Billion |
|
Market Size 2023 |
USD 2.6 Billion |
|
Market Size 2032 |
USD 4.9 Billion |
|
Compound Annual Growth Rate (CAGR) |
8.90% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Condition Type, Treatment, End User, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., and Welch Allyn |
|
Key Market Opportunities |
New product launches and R&D among key players |
|
Key Market Dynamics |
Increasing geriatric population and increasing diabetes retinopathy and other eye diseases |
The global Retinal Detachment market size was valued at USD 2.6 Billion in 2022 and is expected to reach USD 4.9 billion in 2032
The global market is projected to grow at a CAGR of 8.90% during the forecast period, 2023-2032.
North America had the largest share in the global market
The key players in the market are Carl Zeiss Meditec AG, Meridian AG, IRIDEX Corporation, Ellex Medical Lasers Ltd, FCI, Millennium Surgical Corp., BVM Medical Limited, Lombart Instrument, Inc., and Welch Allyn
The Rhegmatogenous Retinal Detachment Condition Type dominated the market in 2022.
The Vitrectomy Treatment had the largest share in the global market.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65232
Published on :
Sep 2023
Request a Free Sample Report
Speak to Analyst